Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Yanning Bao & Weiyue Lu. (2023) Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier. Expert Opinion on Drug Delivery 0:0, pages 1-18.
Read now
Read now
Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Wanying Zhang, Matthew Burrell, Carl I. Webster & Dhaval K. Shah. (2021) Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis. mAbs 13:1.
Read now
Read now
Xiaoxia Guo, Jie Mei & Chunping Zhang. (2020) Development of Drug Dual-Carriers Delivery System with Mitochondria-Targeted and pH/Heat Responsive Capacity for Synergistic Photothermal-Chemotherapy of Ovarian Cancer. International Journal of Nanomedicine 15, pages 301-313.
Read now
Read now
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Joon-Soo Kim & Dong-Kug Choi. (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Delivery 25:1, pages 307-320.
Read now
Read now
Alvise Berti, Giulio Cavalli, Barbara Guglielmi, Riccardo Biavasco, Corrado Campochiaro, Alessandro Tomelleri, Roberto Nicoletti, Andrea Panzacchi, Marina Ferrarini & Lorenzo Dagna. (2017) Tocilizumab in patients with multisystem Erdheim–Chester disease. OncoImmunology 6:6.
Read now
Read now
Roland Thuenauer, Stefan K. Müller & Winfried Römer. (2017) Pathways of protein and lipid receptor-mediated transcytosis in drug delivery. Expert Opinion on Drug Delivery 14:3, pages 341-351.
Read now
Read now
William M. Pardridge. (2016) Re-engineering therapeutic antibodies for Alzheimer’s disease as blood-brain barrier penetrating bi-specific antibodies. Expert Opinion on Biological Therapy 16:12, pages 1455-1468.
Read now
Read now
Maliheh Safavi, Reyhaneh Sabourian & Mohammad Abdollahi. (2016) The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system. Expert Opinion on Drug Discovery 11:10, pages 939-956.
Read now
Read now
Articles from other publishers (97)
Rajan K. Tripathy, J. Anakha & Abhay H. Pande. (2024) Towards development of biobetter: L-asparaginase a case study. Biochimica et Biophysica Acta (BBA) - General Subjects 1868:1, pages 130499.
Crossref
Crossref
Jeffrey Cummings, Amanda M. Leisgang Osse, Davis Cammann, Jayde Powell & Jingchun Chen. (2023) Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease. BioDrugs.
Crossref
Crossref
Atsushi Imakiire, Hideto Morimoto, Hidehiko Suzuki, Tomomi Masuda, Eiji Yoden, Asuka Inoue, Hiroki Morioka, Takashi Konaka, Ayaka Mori, Ryoji Shirasaka, Ryo Kato, Tohru Hirato, Hiroyuki Sonoda & Kohtaro Minami. (2023) Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice. Molecular Pharmaceutics 20:11, pages 5901-5909.
Crossref
Crossref
Jia Nong, Patrick M. Glassman, Jacob W. Myerson, Viviana Zuluaga-Ramirez, Alba Rodriguez-Garcia, Alvin Mukalel, Serena Omo-Lamai, Landis R. Walsh, Marco E. Zamora, Xijing Gong, Zhicheng Wang, Kartik Bhamidipati, Raisa Y. Kiseleva, Carlos H. Villa, Colin Fred Greineder, Scott E. Kasner, Drew Weissman, Michael J. Mitchell, Silvia Muro, Yuri Persidsky, Jacob Samuel Brenner, Vladimir R. Muzykantov & Oscar A. Marcos-Contreras. (2023) Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain. ACS Nano 17:14, pages 13121-13136.
Crossref
Crossref
Simon H. Zientek, Stephen Thompson, Selena Milicevic Sephton & Franklin I. Aigbirhio. (2023) The inverse electron demand Diels–Alder cycloaddition with carbon‐11 and fluorine‐18: A gateway to pretargeted imaging across the blood–brain barrier. Journal of Labelled Compounds and Radiopharmaceuticals 66:9, pages 249-268.
Crossref
Crossref
Angelo Spinello, Fabio Lapenta & Matteo De March. (2023) The avidin‐theophylline complex: A structural and computational study. Proteins: Structure, Function, and Bioinformatics.
Crossref
Crossref
Sachiho Kida, Yuri Koshimura, Eiji Yoden, Aya Yoshioka, Hideto Morimoto, Atsushi Imakiire, Noboru Tanaka, Satowa Tanaka, Ayaka Mori, Jun Ito, Asuka Inoue, Ryuji Yamamoto, Kohtaro Minami, Tohru Hirato, Kenichi Takahashi & Hiroyuki Sonoda. (2023) Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice. Molecular Therapy - Methods & Clinical Development 29, pages 439-449.
Crossref
Crossref
V. V. Smirnov, O. A. Petukhova, A. V. Filatov, D. A. Kudlay & M. R. Khaitov. (2023) Studying the pharmacokinetics of biotechnological medicinal products on the example of monoclonal antibodies. Biological Products. Prevention, Diagnosis, Treatment 23:2, pages 173-180.
Crossref
Crossref
Mohammed Dheyaa Marsool Marsool, Priyadarshi Prajjwal, Yeruva Bheemeswara Reddy, Ali Dheyaa Marsool Marsool, Justin Riley Lam & Varsha Nandwana. (2023) Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases. Disease-a-Month 69:5, pages 101547.
Crossref
Crossref
Valentina D. Gusarova, Maxim A. Smolov, Ivan V. Lyagoskin, Maksim B. Degterev, Elizaveta V. Rechetnik, Alexander V. Rodionov, Marina S. Pantyushenko & Rahim R. Shukurov. (2023) Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome). BioDrugs 37:3, pages 375-395.
Crossref
Crossref
João André Sousa, Catarina Bernardes, Sara Bernardo-Castro, Miguel Lino, Inês Albino, Lino Ferreira, José Brás, Rita Guerreiro, Miguel Tábuas-Pereira, Inês Baldeiras, Isabel Santana & João Sargento-Freitas. (2023) Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target. Frontiers in Aging Neuroscience 15.
Crossref
Crossref
Micael G. Gouveia, Justus P. Wesseler, Jobbe Ramaekers, Christoph Weder, Philip B. V. Scholten & Nico Bruns. (2023) Polymersome-based protein drug delivery – quo vadis?. Chemical Society Reviews 52:2, pages 728-778.
Crossref
Crossref
Andrés de la Rosa, Nicole G. Metzendorf, Jamie I. Morrison, Rebecca Faresjö, Fadi Rofo, Alex Petrovic, Paul O’Callaghan, Stina Syvänen & Greta Hultqvist. (2022) Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood–brain barrier shuttle scFv8D3. Scientific Reports 12:1.
Crossref
Crossref
Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Mahi Mhatre, Anand More, Neelima Anup & Rakesh Kumar Tekade. (2022) Current Update on Transcellular Brain Drug Delivery. Pharmaceutics 14:12, pages 2719.
Crossref
Crossref
Sara Lopes van den Broek, Vladimir Shalgunov & Matthias M. Herth. (2022) Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy. Biomaterials Advances 141, pages 213125.
Crossref
Crossref
Ambra Del Grosso, Gabriele Parlanti, Roberta Mezzena & Marco Cecchini. (2022) Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders. Advanced Drug Delivery Reviews 188, pages 114464.
Crossref
Crossref
Tobias Ruck, Falk Nimmerjahn, Heinz Wiendl & Jan D Lünemann. (2022) Next-generation antibody-based therapies in neurology. Brain 145:4, pages 1229-1241.
Crossref
Crossref
Veronica Natale, Gerhard Stadlmayr, Filippo Benedetti, Katharina Stadlbauer, Florian Rüker & Gordana Wozniak-Knopp. (2022)
Trispecific antibodies produced from mAb
2
pairs by controlled Fab-arm exchange
. Biological Chemistry 403:5-6, pages 509-523.
Crossref
Crossref
Jason M. Lajoie, Moriah E. Katt, Elizabeth A. Waters, Brantley R. Herrin & Eric V. Shusta. (2022) Identification of lamprey variable lymphocyte receptors that target the brain vasculature. Scientific Reports 12:1.
Crossref
Crossref
Annie Arguello, Cathal S. Mahon, Meredith E.K. Calvert, Darren Chan, Jason C. Dugas, Michelle E. Pizzo, Elliot R. Thomsen, Roni Chau, Lorna A. Damo, Joseph Duque, Meng Fang, Tina Giese, Do Jin Kim, Nicholas Liang, Hoang N. Nguyen, Hilda Solanoy, Buyankhishig Tsogtbaatar, Julie C. Ullman, Junhua Wang, Mark S. Dennis, Dolores Diaz, Kannan Gunasekaran, Kirk R. Henne, Joseph W. Lewcock, Pascal E. Sanchez, Matthew D. Troyer, Jeffrey M. Harris, Kimberly Scearce-Levie, Lu Shan, Ryan J. Watts, Robert G. Thorne, Anastasia G. Henry & Mihalis S. Kariolis. (2022) Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme. Journal of Experimental Medicine 219:3.
Crossref
Crossref
Yiming Jin, Megan A. Schladetsch, Xueting Huang, Marcy J. Balunas & Andrew J. Wiemer. (2022) Stepping forward in antibody-drug conjugate development. Pharmacology & Therapeutics 229, pages 107917.
Crossref
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
716
742
.
Dominique Lesuisse. 2022. Drug Delivery to the Brain. Drug Delivery to the Brain
27
69
.
Claire Simonneau, Martina Duschmalé, Alina Gavrilov, Nathalie Brandenberg, Sylke Hoehnel, Camilla Ceroni, Evodie Lassalle, Elena Kassianidou, Hendrik Knoetgen, Jens Niewoehner & Roberto Villaseñor. (2021) Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays. Fluids and Barriers of the CNS 18:1.
Crossref
Crossref
Chenyan Lv, Siyu Huang, Yumeng Wang, Zhaohui Hu, Guanghua Zhao, Changwei Ma & Xueli Cao. (2021) Chicoric acid encapsulated within ferritin inhibits tau phosphorylation by regulating AMPK and GluT1 signaling cascade. Journal of Functional Foods 86, pages 104681.
Crossref
Crossref
Yang Gao, Jianwei Zhu & Huili Lu. (2020) Single domain antibody-based vectors in the delivery of biologics across the blood–brain barrier: a review. Drug Delivery and Translational Research 11:5, pages 1818-1828.
Crossref
Crossref
Ewen Se Thoe, Ayesha Fauzi, Yin Quan Tang, Sunita Chamyuang & Adeline Yoke Yin Chia. (2021) A review on advances of treatment modalities for Alzheimer's disease. Life Sciences 276, pages 119129.
Crossref
Crossref
Hideto Morimoto, Sachiho Kida, Eiji Yoden, Masafumi Kinoshita, Noboru Tanaka, Ryuji Yamamoto, Yuri Koshimura, Haruna Takagi, Kenichi Takahashi, Tohru Hirato, Kohtaro Minami & Hiroyuki Sonoda. (2021) Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice. Molecular Therapy 29:5, pages 1853-1861.
Crossref
Crossref
Marieke Olsman, Viktoria Sereti, Melina Mühlenpfordt, Kasper Bendix Johnsen, Thomas Lars Andresen, Andrew James Urquhart & Catharina de Lange Davies. (2021) Focused Ultrasound and Microbubble Treatment Increases Delivery of Transferrin Receptor-Targeting Liposomes to the Brain. Ultrasound in Medicine & Biology 47:5, pages 1343-1355.
Crossref
Crossref
Anisha D'Souza, Kandarp M. Dave, R. Anne Stetler & Devika S. Manickam. (2021) Targeting the blood-brain barrier for the delivery of stroke therapies. Advanced Drug Delivery Reviews 171, pages 332-351.
Crossref
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Crossref
Xue Xia, Yang Zhou & Huile Gao. (2021) Prodrug strategy for enhanced therapy of central nervous system disease. Chemical Communications.
Crossref
Crossref
Alec A. Desai, Matthew D. Smith, Yulei Zhang, Emily K. Makowski, Julia E. Gerson, Edward Ionescu, Charles G. Starr, Jennifer M. Zupancic, Shannon J. Moore, Alexandra B. Sutter, Magdalena I. Ivanova, Geoffrey G. Murphy, Henry L. Paulson & Peter M. Tessier. (2021) Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity. Journal of Biological Chemistry 296, pages 100508.
Crossref
Crossref
Thuy Trang Nguyen, Tuong Kha Vo & Giau Van Vo. 2021. Reviews on New Drug Targets in Age-Related Disorders. Reviews on New Drug Targets in Age-Related Disorders
183
198
.
Mei Mei Tian & Reinhard Gabathuler. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
119
147
.
Jian Ren, Fuxin Jiang, Ming Wang, Haodong Hu, Bo Zhang, Li Chen & Fengying Dai. (2020) Increased cross-linking micelle retention in the brain of Alzheimer's disease mice by elevated asparagine endopeptidase protease responsive aggregation. Biomaterials Science 8:23, pages 6533-6544.
Crossref
Crossref
William M. Pardridge. (2020) Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain. Frontiers in Medical Technology 2.
Crossref
Crossref
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Demi M. Castellanos, Jiahong Sun, Joshua Yang, Weijun Ou, Alexander C. Zambon, William M. Pardridge & Rachita K. Sumbria. (2020) Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice. Pharmaceutics 12:9, pages 852.
Crossref
Crossref
Julia V. Georgieva, Loukas I. Goulatis, Charles C. Stutz, Scott G. Canfield, Hannah W. Song, Benjamin D. Gastfriend & Eric V. Shusta. (2020) Antibody screening using a human iPSC‐based blood‐brain barrier model identifies antibodies that accumulate in the CNS. The FASEB Journal 34:9, pages 12549-12564.
Crossref
Crossref
Deborah Young. (2020) The NMDA Receptor Antibody Paradox: A Possible Approach to Developing Immunotherapies Targeting the NMDA Receptor. Frontiers in Neurology 11.
Crossref
Crossref
Tuo Liang, Zhong-Ming Qian, Ming-Dao Mu, Wing-Ho Yung & Ya Ke. (2020) Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism. iScience 23:7, pages 101284.
Crossref
Crossref
Sunil Kumar Dubey, K.K. Lakshmi, Kowthavarapu Venkata Krishna, Mukta Agrawal, Gautam Singhvi, Ranendra Narayana Saha, Swarnlata Saraf, Shailendra Saraf, Rahul Shukla & Amit Alexander. (2020) Insulin mediated novel therapies for the treatment of Alzheimer's disease. Life Sciences 249, pages 117540.
Crossref
Crossref
Norman C. Peterson, Prathap Kumar Mahalingaiah, Aaron Fullerton & Matteo Di Piazza. (2020) Application of microphysiological systems in biopharmaceutical research and development. Lab on a Chip 20:4, pages 697-708.
Crossref
Crossref
Yaping Ju, Hao Guo, Maria Edman & Sarah F. Hamm-Alvarez. (2020) Application of advances in endocytosis and membrane trafficking to drug delivery. Advanced Drug Delivery Reviews 157, pages 118-141.
Crossref
Crossref
Jindřich Kopeček & Jiyuan Yang. (2020) Polymer nanomedicines. Advanced Drug Delivery Reviews 156, pages 40-64.
Crossref
Crossref
Jinbing Xie, Zheyu Shen, Yasutaka Anraku, Kazunori Kataoka & Xiaoyuan Chen. (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224, pages 119491.
Crossref
Crossref
María Sofía Castelli, Paul McGonigle & Pamela J. Hornby. (2019) The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacology Research & Perspectives 7:6.
Crossref
Crossref
Ulapane, Kopec & Siahaan. (2019) Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides. Pharmaceutics 11:11, pages 568.
Crossref
Crossref
A. R. Satvik Iyengar, Shreya Gupta, Snehal Jawalekar & Abhay H. Pande. (2019) Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics 370:3, pages 703-714.
Crossref
Crossref
Lindsey A. Crawford, Hannah C. Watkins, Elizabeth Wayne & David Putnam. (2019) Altered Biodistribution and Tissue Retention of Nanoparticles Targeted with P-Glycoprotein Substrates. Regenerative Engineering and Translational Medicine 5:3, pages 308-318.
Crossref
Crossref
Jiahong Sun, Ruben J. Boado, William M. Pardridge & Rachita K. Sumbria. (2019) Plasma Pharmacokinetics of High-Affinity Transferrin Receptor Antibody-Erythropoietin Fusion Protein is a Function of Effector Attenuation in Mice. Molecular Pharmaceutics 16:8, pages 3534-3543.
Crossref
Crossref
Tae-Eun Park, Nur Mustafaoglu, Anna Herland, Ryan Hasselkus, Robert Mannix, Edward A. FitzGerald, Rachelle Prantil-Baun, Alexander Watters, Olivier Henry, Maximilian Benz, Henry Sanchez, Heather J. McCrea, Liliana Christova Goumnerova, Hannah W. Song, Sean P. Palecek, Eric Shusta & Donald E. Ingber. (2019) Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nature Communications 10:1.
Crossref
Crossref
Jiahong Sun, Jan Michelle Martin, Victoria Vanderpoel & Rachita K. Sumbria. (2019) The Promises and Challenges of Erythropoietin for Treatment of Alzheimer’s Disease. NeuroMolecular Medicine 21:1, pages 12-24.
Crossref
Crossref
Zui Zhang & Changyou Zhan. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
105
128
.
Guangzhe Li, Kun Shao & Channakeshava Sokke Umeshappa. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
33
51
.
William M. Pardridge, Ruben J. Boado, Daniel J. Patrick, Eric Ka-Wai Hui & Jeff Zhiqiang Lu. (2018) Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor. Molecular Pharmaceutics 15:11, pages 5207-5216.
Crossref
Crossref
Rudy Chang, Abrar Al Maghribi, Victoria Vanderpoel, Vitaly Vasilevko, David H. Cribbs, Ruben Boado, William M. Pardridge & Rachita K. Sumbria. (2018) Brain Penetrating Bifunctional Erythropoietin–Transferrin Receptor Antibody Fusion Protein for Alzheimer’s Disease. Molecular Pharmaceutics 15:11, pages 4963-4973.
Crossref
Crossref
Cinzia M. Bellettato & Maurizio Scarpa. (2018) Possible strategies to cross the blood–brain barrier. Italian Journal of Pediatrics 44:S2.
Crossref
Crossref
Bushra Husain & Diego Ellerman. (2018) Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies. BioDrugs 32:5, pages 441-464.
Crossref
Crossref
Stephanie M. CurleyNathaniel C. Cady. (2018) Biologically-Derived Nanomaterials for Targeted Therapeutic Delivery to the Brain. Science Progress 101:3, pages 273-292.
Crossref
Crossref
Rui Xue Zhang, Jason Li, Tian Zhang, Mohammad A Amini, Chunsheng He, Brian Lu, Taksim Ahmed, HoYin Lip, Andrew M Rauth & Xiao Yu Wu. (2018) Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples. Acta Pharmacologica Sinica 39:5, pages 825-844.
Crossref
Crossref
Hiroyuki Sonoda, Hideto Morimoto, Eiji Yoden, Yuri Koshimura, Masafumi Kinoshita, Galina Golovina, Haruna Takagi, Ryuji Yamamoto, Kohtaro Minami, Akira Mizoguchi, Katsuhiko Tachibana, Tohru Hirato & Kenichi Takahashi. (2018) A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II. Molecular Therapy 26:5, pages 1366-1374.
Crossref
Crossref
Kun Cao, Jing Zhang, Xin-Yu Miao, Qiu-Xia Wei, Xin-Lu Zhao, Qing-Yu He & Xuesong Sun. (2018) Evolution and molecular mechanism of PitAs in iron transport of Streptococcus species. Journal of Inorganic Biochemistry 182, pages 113-123.
Crossref
Crossref
Boris Tchernychev, Talia Miron & Meir Wilchek. (2018) Epitope identification of specific naturally occurring human anti-avidin antibodies. Immunology Letters 196, pages 119-123.
Crossref
Crossref
Chunsheng He, Jason Li, Ping Cai, Taksim Ahmed, Jeffrey T. Henderson, Warren D. Foltz, Reina Bendayan, Andrew Michael Rauth & Xiao Yu Wu. (2018) Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer. Advanced Functional Materials 28:9, pages 1705668.
Crossref
Crossref
Christopher D. Spicer, Coline Jumeaux, Bakul Gupta & Molly M. Stevens. (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. Chemical Society Reviews 47:10, pages 3574-3620.
Crossref
Crossref
Kamla Pathak & Ankur Vaidya. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery
163
190
.
Teruyuki Nagamune. (2017) Biomolecular engineering for nanobio/bionanotechnology. Nano Convergence 4:1.
Crossref
Crossref
Yung‐Hao Tsou, Xue‐Qing Zhang, He Zhu, Sahla Syed & Xiaoyang Xu. (2017) Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials. Small 13:43.
Crossref
Crossref
Waranyoo Phoolcharoen, Christophe Prehaud, Craig J. van Dolleweerd, Leonard Both, Anaelle da Costa, Monique Lafon & Julian K-C. Ma. (2017)
Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an
in cellulo
blood-brain barrier device
. Plant Biotechnology Journal 15:10, pages 1331-1339.
Crossref
Crossref
Rong Yang, Tuo Wei, Hannah Goldberg, Weiping Wang, Kathleen Cullion & Daniel S. Kohane. (2017) Getting Drugs Across Biological Barriers. Advanced Materials 29:37.
Crossref
Crossref
Fei Fang, Dan Zou, Wei Wang, Ying Yin, Tieying Yin, Shilei Hao, Bochu Wang, Guixue Wang & Yazhou Wang. (2017) Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport. Materials Science and Engineering: C 76, pages 1316-1327.
Crossref
Crossref
Li-Min Mu, Ying-Zi Bu, Lei Liu, Hong-Jun Xie, Rui-Jun Ju, Jia-Shuan Wu, Fan Zeng, Yao Zhao, Jing-Ying Zhang & Wan-Liang Lu. (2017) Lipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cells. Scientific Reports 7:1.
Crossref
Crossref
Célia Faustino, Patrícia Rijo & Catarina Pinto Reis. (2017) Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer’s disease. Pharmacological Research 120, pages 68-87.
Crossref
Crossref
Mayur M. Patel & Bhoomika M. Patel. (2017) Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain. CNS Drugs 31:2, pages 109-133.
Crossref
Crossref
Dimple Sethi Chopra. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
229
245
.
Dimple Sethi Chopra. 2017. Advancing Medicine through Nanotechnology and Nanomechanics Applications. Advancing Medicine through Nanotechnology and Nanomechanics Applications
118
139
.
Akshay Jain & Kun Cheng. (2017) The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. Journal of Controlled Release 245, pages 27-40.
Crossref
Crossref
N. Tsomaia, M. Ufret, A. Bhat & J. Nakhle. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
326
348
.
Denise C. Hsu & Jintanat Ananworanich. 2018. HIV-1 Latency. HIV-1 Latency
181
210
.
Ian A. Clark & Bryce Vissel. (2016) Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. Journal of Neuroinflammation 13:1.
Crossref
Crossref
Shimao Zhu & Caiping Guo. (2016) Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential. Viruses 8:11, pages 279.
Crossref
Crossref
Lindsey Crawford, Justin Rosch & David Putnam. (2016) Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system. Journal of Controlled Release 240, pages 251-266.
Crossref
Crossref
Konstantina Papadia, Eleni Markoutsa & Sophia G. Antimisiaris. (2016) How do the physicochemical properties of nanoliposomes affect their interactions with the hCMEC/D3 cellular model of the BBB?. International Journal of Pharmaceutics 509:1-2, pages 431-438.
Crossref
Crossref
Huile Gao. (2016) Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B 6:4, pages 268-286.
Crossref
Crossref
Yajnavalka Banerjee, Raul D. Santos, Khalid Al-Rasadi & Manfredi Rizzo. (2016) Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?. Atherosclerosis 248, pages 62-75.
Crossref
Crossref
Jing-Zhang Wang, Ning Xiao, Ying-Zhou Zhang, Chao-Xian Zhao, Xin-Hua Guo & Li-Min Lu. (2016) Mfsd2a-based pharmacological strategies for drug delivery across the blood–brain barrier. Pharmacological Research 104, pages 124-131.
Crossref
Crossref
Sadhana Jackson, Nicole M. Anders, Antonella Mangraviti, Teresia M. Wanjiku, Eric W. Sankey, Ann Liu, Henry Brem, Betty Tyler, Michelle A. Rudek & Stuart A. Grossman. (2015) The effect of regadenoson-induced transient disruption of the blood?brain barrier on temozolomide delivery to normal rat brain. Journal of Neuro-Oncology 126:3, pages 433-439.
Crossref
Crossref
Vera Neves, Frederico Aires-da-Silva, Sofia Corte-Real & Miguel A.R.B. Castanho. (2016) Antibody Approaches To Treat Brain Diseases. Trends in Biotechnology 34:1, pages 36-48.
Crossref
Crossref
Gert Fricker & Anne Mahringer. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
16
.
David V. Gauvin, Zachary J. Zimmermann & Theodore J. Baird. (2015) Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies. Regulatory Toxicology and Pharmacology 73:1, pages 43-54.
Crossref
Crossref
Tina Skjørringe, Annette Burkhart, Kasper Bendix Johnsen & Torben Moos. (2015) Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Frontiers in Molecular Neuroscience 8.
Crossref
Crossref
Claire Legendre & Emmanuel Garcion. (2015) Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies. Trends in Endocrinology & Metabolism 26:6, pages 322-331.
Crossref
Crossref
Rameshwar Patil, Alexander V. Ljubimov, Pallavi R. Gangalum, Hui Ding, Jose Portilla-Arias, Shawn Wagner, Satoshi Inoue, Bindu Konda, Arthur Rekechenetskiy, Alexandra Chesnokova, Janet L. Markman, Vladimir A. Ljubimov, Debiao Li, Ravi S. Prasad, Keith L. Black, Eggehard Holler & Julia Y. Ljubimova. (2015) MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain. ACS Nano 9:5, pages 5594-5608.
Crossref
Crossref
Marc-Antoine Lauzon, Alex Daviau, Bernard Marcos & Nathalie Faucheux. (2015) Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease. Journal of Controlled Release 206, pages 187-205.
Crossref
Crossref
Huiyuan Wang, Yifan Jiang, Huige Peng, Yingzhi Chen, Peizhi Zhu & Yongzhuo Huang. (2015) Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors. Advanced Drug Delivery Reviews 81, pages 142-160.
Crossref
Crossref